英文摘要 |
Obesity is an important factor causing non-alcoholic fatty liver disease (NAFLD). Weight loss is regarded as an important method for the treatment of NFALD, and the goal is to lose 7%-10% of total body weight. Among the non-drug treatments for NAFLD, diet and exercise remain the key therapeutic elements in combating NAFLD. Recent studies have highlighted the importance of calorie restriction regardless of dietary composition. In addition, the Mediterranean diet has been shown to significantly improve important risk factors for NAFLD. More and more evidence support the harmful effect of alcohol on NAFLD, and recent guidelines also recommend that people with NAFLD should abstain from alcohol. Exercise patterns can be tailored according to the patient's preferences, and both aerobic exercise and resistance training can be used to ensure long-term adherence. Diet and exercise often fail to achieve sustained weight loss in severely obese patients. Metabolic surgery can achieve effective and sustained weight loss, and has been regarded as the best way to treat severely obese patients. Metabolic surgery can result in 25-35% of total body weight loss and long-term improvement in NAFLD. Although endoscopic bariatric and metabolic therapies have also been proven to improve NAFLD, most studies are derived from intragastric balloons. Intragastric balloons can result in 13.2% of total body weight loss, but the mean follow-up time is only 6 months. Endoscopic sleeve gastroplasty can maintain more sustained weight loss, but its effect on NAFLD requires more research. Methods such as prebiotics, probiotics and fecal microbiota transplantation are used to modulate the gut microbiota. However, further research is also needed to elucidate their effects on NAFLD. |